Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Viral load markedly reduced by Invirase + Norvir

Nov. 15, 1996

Lead HIV protease inhibitor from ArQule

Nov. 15, 1996

HIV protease inhibitors described by DuPont

Nov. 15, 1996

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

Cel-Sci reports interim results from AIDS vaccine trial

Nov. 8, 1996

Spanish phase II trial to evaluate Remune in combination with antiviral agents

Nov. 8, 1996

Procept and MRC clinical collaboration on topical microbicide

Nov. 8, 1996

Novel nontoxic AIDS drug cleared for clinical trials

Nov. 8, 1996

Expanded access allowed for NTZ in AIDS patients

Nov. 8, 1996

Sankyo describes anti-HIV agents

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...